Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Muhammad Salim

Showing results (91-100 of 121) with videos related to

Pageof 13
Sort By:
Breast Cancer Research and Treatment|April 27, 2016
Canadian Cancer Trials Group IND197: a phase II study of foretinib in patients with estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2-negative recurrent or metastatic breast cancerDaniel Rayson, Sasha Lupichuk, Kylea Potvin, et al.
Plos One|November 19, 2021
The burden of SARS-CoV-2 among healthcare workers across 16 hospitals of Kashmir, India-A seroepidemiological studyInaamul Haq, Mariya Amin Qurieshi, Muhammad Salim Khan, et al.
Leukemia & Lymphoma|October 19, 2016
The CDK inhibitor AT7519M in patients with relapsed or refractory chronic lymphocytic leukemia (CLL) and mantle cell lymphoma. A Phase II study of the Canadian Cancer Trials GroupMatthew D Seftel, John Kuruvilla, Tom Kouroukis, et al.
Cancers|April 13, 2023
Outcomes of Rural Men with Breast Cancer: A Multicenter Population Based Retrospective Cohort StudyLucas A B Fisher, Osama Ahmed, Haji Ibraheem Chalchal, et al.
International Journal of Radiation Oncology, Biology, Physics|July 6, 2004
Long-term results of a phase III trial comparing once-daily radiotherapy with twice-daily radiotherapy in limited-stage small-cell lung cancerSteven E Schild, James A Bonner, Thomas G Shanahan, et al.
Plos One|November 11, 2020
Seroprevalence of SARS-CoV-2 specific IgG antibodies in District Srinagar, northern India - A cross-sectional studyS Muhammad Salim Khan, Mariya Amin Qurieshi, Inaamul Haq, et al.
Neuro-Oncology|January 22, 2015
Phase II study of PX-866 in recurrent glioblastomaMarshall W Pitz, Elizabeth A Eisenhauer, Mary V MacNeil, et al.
Frontiers in Chemistry|December 13, 2023
Towards sustainable electrochemistry: green synthesis and sintering aid modulations in the development of BaZr<sub>0.87</sub>Y<sub>0.1</sub>M<sub>0.03</sub>O<sub>3-δ</sub> (M = Mn, Co, and Fe) IT-SOFC electrolytesQurat Ul Ain, Muneeb Irshad, Muhammad Salim Butt, et al.
Journal of the National Cancer Institute|March 17, 2018
Supplement Use and Chemotherapy-Induced Peripheral Neuropathy in a Cooperative Group Trial (S0221): The DELCaP StudyGary R Zirpoli, Susan E McCann, Lara E Sucheston-Campbell, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 2004
Prognostic value of proliferation, apoptosis, defective DNA mismatch repair, and p53 overexpression in patients with resected Dukes' B2 or C colon cancer: a North Central Cancer Treatment Group StudyMegan M Garrity, Lawrence J Burgart, Michelle R Mahoney, et al.
Pageof 13

Showing results (91-100 of 121) with videos related to

Sort By:
Pageof 13
Breast Cancer Research and Treatment|April 27, 2016
Canadian Cancer Trials Group IND197: a phase II study of foretinib in patients with estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2-negative recurrent or metastatic breast cancerDaniel Rayson, Sasha Lupichuk, Kylea Potvin, et al.
Plos One|November 19, 2021
The burden of SARS-CoV-2 among healthcare workers across 16 hospitals of Kashmir, India-A seroepidemiological studyInaamul Haq, Mariya Amin Qurieshi, Muhammad Salim Khan, et al.
Leukemia & Lymphoma|October 19, 2016
The CDK inhibitor AT7519M in patients with relapsed or refractory chronic lymphocytic leukemia (CLL) and mantle cell lymphoma. A Phase II study of the Canadian Cancer Trials GroupMatthew D Seftel, John Kuruvilla, Tom Kouroukis, et al.
Cancers|April 13, 2023
Outcomes of Rural Men with Breast Cancer: A Multicenter Population Based Retrospective Cohort StudyLucas A B Fisher, Osama Ahmed, Haji Ibraheem Chalchal, et al.
International Journal of Radiation Oncology, Biology, Physics|July 6, 2004
Long-term results of a phase III trial comparing once-daily radiotherapy with twice-daily radiotherapy in limited-stage small-cell lung cancerSteven E Schild, James A Bonner, Thomas G Shanahan, et al.
Plos One|November 11, 2020
Seroprevalence of SARS-CoV-2 specific IgG antibodies in District Srinagar, northern India - A cross-sectional studyS Muhammad Salim Khan, Mariya Amin Qurieshi, Inaamul Haq, et al.
Neuro-Oncology|January 22, 2015
Phase II study of PX-866 in recurrent glioblastomaMarshall W Pitz, Elizabeth A Eisenhauer, Mary V MacNeil, et al.
Frontiers in Chemistry|December 13, 2023
Towards sustainable electrochemistry: green synthesis and sintering aid modulations in the development of BaZr<sub>0.87</sub>Y<sub>0.1</sub>M<sub>0.03</sub>O<sub>3-δ</sub> (M = Mn, Co, and Fe) IT-SOFC electrolytesQurat Ul Ain, Muneeb Irshad, Muhammad Salim Butt, et al.
Journal of the National Cancer Institute|March 17, 2018
Supplement Use and Chemotherapy-Induced Peripheral Neuropathy in a Cooperative Group Trial (S0221): The DELCaP StudyGary R Zirpoli, Susan E McCann, Lara E Sucheston-Campbell, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 2004
Prognostic value of proliferation, apoptosis, defective DNA mismatch repair, and p53 overexpression in patients with resected Dukes' B2 or C colon cancer: a North Central Cancer Treatment Group StudyMegan M Garrity, Lawrence J Burgart, Michelle R Mahoney, et al.
Pageof 13